MS, RRT-ACCS, NPS, AE-C
David L Vines,
MHS, PhD, RRT, FAARC
As our aging population grows, so does the prevalence of respiratory-related ailments. To meet this medical need, a variety of new respiratory diagnostic and treatment options are being developed. With the availability of these new options, respiratory care professionals will require the most up-to-date, scientifically- and clinically-based information to help them make informed decisions on what is best for their patients.
Clinical Foundations provides practical, clinically- and evidenced-based articles, case studies and symposia for respiratory therapists and respiratory care directors, managers, and supervisors. Clinical Foundations is based on a patient-focused model of care that emphasizes the need to provide the care and services that focus on patients’ individual needs and preferences.
As part of our commitment to helping respiratory care professionals improve their skills, each edition of Clinical Foundations is fully accredited by the AARC for CRCEs.
New Online Module
By Matt Hegewald, MD
Aerosol therapy is the cornerstone for treating asthma and Chronic Obstructive Pulmonary Disease (COPD). Many aerosol devices are available, including the pressurized metered dose inhaler, the dry powder inhaler, the slow/soft mist inhaler, and the nebulizer. Each device has its particular advantages and disadvantages. The asthma and COPD guidelines stress the importance of matching the patient to the aerosol delivery device. Providers need to be aware of the advantages and disadvantages of the available devices. Given the absence of evidence that one aerosol delivery system is superior to another, as long as they are used correctly, patient preference, convenience, available drug formulations and cost will be the determining factors in choosing a device. For those patients not capable of using handheld delivery devices adequately, nebulizers are the preferred aerosol delivery devices.
Moderator: Arzu Ari, PhD, RRT, PT, CPFT, FAARC
There has been a growing interest in the development of new aerosol technologies over the years. New directions and technical innovations in aerosol medicine give clinicians access to new devices. However, adopting new aerosol technologies for the treatment of patients with pulmonary diseases brings many challenges and strategic barriers such as unfamiliarity, confusion and misuse of the device by patients due to device dementia as well as lack of knowledge and experience with the novel device in clinical practice. It is important to overcome these barriers for successful implementation of new technologies in aerosol medicine. In this issue of Clinical Foundations, Drs. Bruce Rubin, James B. Fink and Sandra Adams, who have a wealth of experience and knowledge in aerosol medicine, provide valuable suggestions to clinicians who want to adopt new technologies in their clinical practice. They also provide detailed and comprehensive information on new directions in aerosol medicine, the importance of patient education and adherence, the risks with concomitant therapy and the factors that need to be considered for the selection of a nebulizer. This is your opportunity to improve your knowledge and expertise that will empower you as a clinician for the benefit of your patients.
Richard Branson, MS, RRT, FAARC
Professor of Surgery
University of Cincinnati College of Medicine
Kathleen Deakins, MS, RRT, NPS
Supervisor, Pediatric Respiratory Care
Rainbow Babies & Children’s Hospital of University Hospitals
William Galvin, MSEd, RRT, CPFT, AE-C, FAARC
Program Director, Respiratory Care Program
Gwynedd Mercy College,
Gwynedd Valley, PA.
Carl Haas, MS, RRT, FAARC
Educational & Research Coordinator
University Hospitals and Health Centers
Ann Arbor, MI
Richard Kallet, MSc, RRT, FAARC
Clinical Projects Manager
University of California Cardiovascular Research Institute San Francisco, CA
Neil MacIntyre, MD, FAARC
Medical Director of Respiratory Services
Duke University Medical Center
Tim Myers, BS, RRT-NPS
Chief Business Officer, AARC
Tim Op’t Holt, EdD, RRT, AE-C, FAARC
Professor, Department of Respiratory Care and Cardiopulmonary Sciences University of Southern Alabama
Helen Sorenson, MA, RRT, FAARC
Assistant Professor, Dept. of
University of Texas Health Sciences Center
San Antonio, TX
This program is sponsored by Teleflex